Joint Transnational Call (JTC2009)

These projects were funded under E-Rare.

Factsheet (PDF)

General information
Topic: European Research Projects on Rare Diseases
Budget: 11,3 Million €
Funded projects: 16
The following parties have decided to open the second joint call for funding multilateral research projects on rare diseases

  • The National Research Agency (ANR), France
  • The Federal Ministry of Education and Research (BMBF), Germany
  • The Chief Scientist Office of the Ministry of Health (CSMOH), Israel
  • The Institute of Health Carlos III (ISCIII), Spain
  • The Scientific and Technological Research Council of Turkey (TÜBITAK), Turkey
  • The Netherlands Organisation for Health Research and Development (ZonMw), The Netherlands
  • The Foundation for Science and Technology (FCT), Portugal
  • The National Institute of Health (ISS), Italy
  • The Austrian Science Fund (FWF), Austria
  • The Ministry of Development – General Secretariat for Research and Technology (GSRT), Greece 
  • CAV-4-MPS: Understanding and treating neurodegeneration caused by mucopolysaccharidoses
  • Cure-FXS: Targeting Rho-signalling, a new therapeutic avenue in fragile X syndrome
  • EB: Identification of revertant mosaicism in epidermolysis bullosa and subsequently using the revertant keratinocytes in a pre-clinical mouse model suitable to test revertant cell therapy
  • ELA2-CN: Congenital neutropenia with ELA-2 mutations (ELA2-CN): Identification of (epi)genetic co-factors and molecular pathways underlying clinical heterogeneity
  • EMINA: European Multidisciplinary Initiative on Neuroacanthocytosis
  • EuPAPNet: European pulmonary alveolar proteinosis network : molecular determinants of causes, variability and outcome
  • EURO-CDG: Genetics and pathogenesis of chronic granulomatous disease and development of new gene transfer therapeutic approaches
  • EuroGeBeta: European network on genetics, pathophysiology and translational research into rare pancreatic beta-cell insufficiency diseases
  • GETHERTHAL: Improvements of vector technology and safety for the gene therapy of thalassemia
  • HMA-IRON: Towards improved diagnosis and treatment of rare inherited microcytic hypochromic anemias related to iron metabolism
  • MLC-Teams: Megalencephalic leukoencephalopathy with subcortical cysts: from molecular basis to search for therapy
  • NEMMYOP: Functional characterization of nemaline myopathy in a murine model with nebulin mutation: moving from basic understanding towards therapeutic interventions
  • NEUTRO-NET: Inherited inhibition of inborn immunity – an integrated molecular genetic approach to discover novel human gene defects
  • NsEuroNet: European network on noonan syndrome and related disorders
  • RHORCOD: Comprehensive analysis of rod-cone photoreceptor degeneration associated with rhodopsin gene mutations